Article

Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption

2022-08-26

Abstract excerpt

The continual emergence of new SARS-CoV-2 variants threatens the effectiveness of worldwide vaccination programs and highlights the need for complementary strategies for a sustainable containment plan. A promising approach is to mobilize the body⍰s own antimicrobial peptides (AMPs), to combat SARS-CoV-2 infection and propagation. We have found that human cathelicidin (LL37), an AMP found at epithelial barriers as...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0c0264ce-73e5-5c0f-aaa8-2d4468714013
DOI: 10.1101/2022.08.26.505399

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruptionDOI 10.1101/2022.08.26.505399Read

A stapled lipopeptide platform for preventing and treating highly pathogenic viruses of pandemic potentialSemantic proximity Read

An Overview of Antiviral Peptides and Rational Biodesign ConsiderationsSemantic proximity Read

Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cellSemantic proximity Read

Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus RealitySemantic proximity Read

Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the UK B.1.1.7 and SA B.1.351 variantSemantic proximity Read

HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19Semantic proximity Read

An Update of Peptides With Therapeutic Potential Against <em>Acinetobacter baumannii </em>InfectionsSemantic proximity Read

Molecular interaction modes of the host-defense peptide cathelicidin LL-37 and its mutants dictate diverse antimicrobial activities.Semantic proximity Read

An in silico scientific basis for LL ‐37 as a therapeutic for Covid‐19Semantic proximity Read

nanoCLAMP potently neutralizes SARS-CoV-2 and protects K18-hACE2 mice from infectionSemantic proximity Read

Modulation of the human cathelicidin dimerization interface separates antimicrobial activity from mammalian membrane disruptionSemantic proximity Read

Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor DesignSemantic proximity Read